Team:BIOSINT Mexico/kuxtal

From 2012e.igem.org

(Difference between revisions)
 
(7 intermediate revisions not shown)
Line 124: Line 124:
             <div class="grid_23 prefix_1">
             <div class="grid_23 prefix_1">
             <h2 class="h2 top-3"></h2>
             <h2 class="h2 top-3"></h2>
-
<div class="text-1-1"><span>  </span><strong>Kuxtal</strong></div>
+
<div class="text-1-1"><span>  </span><strong>The company</strong></div>
                 <div class="wrap top-9">
                 <div class="wrap top-9">
                     <div class="p-border">
                     <div class="p-border">
                             <div class="wrap">
                             <div class="wrap">
-
                                 <p class="clr-1">Business concept.</p>
+
                                 <p class="clr-1"><strong>Business concept.</strong></p>
                             </div>
                             </div>
-
                             <p>Kuxtal Biotech is a mexican company that will provide solutions and genomic services contributing with the development of synthetic biology projects. It is focused on customized gene synthesis, validation and technical assistance. Kuxtal Biotech, initially established in Querétaro, shapes as an area pioneer in México that, thanks to its value proposition and growing target market, will contribute with scientific, technological and economic development within the country. Currently, the company is:
+
                             <p>Kuxtal Biotech is a mexican young company founded by 16 biotechnology engineers that will provide solutions and genomic services to it's target market: biotechnology laboratories, college laboratories, medical and private institutions, and research centers. It is focused on customized gene synthesis, validation and technical assistance.</p>
-
• Establishing strategic relationships in order to attract investors.
+
-
• Working on research and developing planning.
+
-
• Gathering together all the elements in order to start operations.</p>
+
                         </div>
                         </div>
               </div>
               </div>
Line 140: Line 137:
                     <div class="p-border">
                     <div class="p-border">
                             <div class="wrap">
                             <div class="wrap">
-
                                 <p class="clr-1">Business philosophy.</p>
+
                                 <p class="clr-1"><strong>Business philosophy.</strong></p>
                             </div>
                             </div>
-
                             <p>Kuxtal Biotech’s Mission is to improve the life quality of all human being by enhancing the development of science through nthetic biology projects and bioengineering projects.</br></br> As our vision, in 2020 Kuxtal Biotech will be a recognized company in the oligonucleotide synthesis area by the quality, delivery time and response time in all the products and services provided. In 2025, Kuxtal Biotech will be a consolidated company at international level that will take the values in an intrinsic way and will be reflected in every member with a relationship with the enterprise. We will be the first option of the majority of the most important companies in México.</br></br> The values that Kuxtal will manage are a) Innovation: we are always generating new ideas and making them come true. This is an enterprise that is always continuously improving. b) Team Work: as we always have done, we promote the work team in order to look for a common objective and success. c) Ethical and Reliable: we always behave in ethical ways and are reliable for customers, suppliers and member of our team.</p>
+
                             <p>Kuxtal Biotech's mission is to improve the quality of life of all human beings by enhancing the production and supply of effective medicines and treatments that will make use of synthetic biology/biotechnology knowledge.</br></br> As our vision, In 2020, Kuxtal Biotech will be a recognized company in gene synthesis production and synthetic biology area because of the excellence in quality as well as early delivery time in all the products and services provided.</br></br> The values that Kuxtal will manage are:</br> a) Innovation-By generating new ideas and making them come true. The company will be always looking for new biotechnological processes and services to offer.</br> b) Team work-By promoting share of ideas, efficient communication and coordinate activities to reach common objectives.</br> c) Ethics ans realiability- By behaving in a honest and responsable way, always trying to satisfy our customers with useful services and products.</p>
                         </div>
                         </div>
Line 150: Line 147:
                     <div class="p-border">
                     <div class="p-border">
                             <div class="wrap">
                             <div class="wrap">
-
                                 <p class="clr-1">Services provided.</p>
+
                                 <p class="clr-1"><strong>Services provided.</strong></p>
                             </div>
                             </div>
-
                             <p>Vivamus hendrerit mauris ut dui. gravida ut viverra lectus tincidunt. Cras mattis tempor eros nec tristique. Sed sed felis arcu, vel vehicula augue. Maecenas faucibus sagittis cursus. </p>
+
                             <p>Kuxtal Biotech provides oligonucleotide synthesis services, as well as assessment and consulting services.</br></br>
 +
The synthesis services will be performed with the highest quality standards with the services provided by Kuxtal biotech as the fastest in the market, and the consulting services provided in real time. The main focus of the synthesis will be primer synthesis for PCR techniques for the range between 20 and 30 bp, however other services will be available such as RNA and DNA synthesis for antisense and silencing techniques.</br></br>
 +
Kuxtal biotech will be ready to deliver gene synthesis of complex traits in the vector that the customer specifies. Synthesis products will be delivered lyophilized in 2 mL vials on a dry-ice container, along with a certificate of analysis that ensures quality. The products should be resuspended prior use, or stored at -20°C if they are to be used within a year from the synthesis date. Shipping costs will be charged to the customer.</br></br>
 +
As part of the quality promise, Kuxtal Biotech will evaluate all orders submitted and provide feedback to its costumers whenever possible to ensure every synthesis meets the needs and expectations of the clients.
 +
</p>
                         </div>
                         </div>
Line 160: Line 161:
                     <div class="p-border">
                     <div class="p-border">
                             <div class="wrap">
                             <div class="wrap">
-
                                 <p class="clr-1">Competitive advantage.</p>
+
                                 <p class="clr-1"><strong>Competitive advantage.</strong></p>
                             </div>
                             </div>
-
                             <p>The Kuxtal’s competitive advantage includes the offering of gene synthesis services within México, minimizing intermediaries and regulatory bottlenecks, avoiding delivery times. Other characteristics of the company are:
+
                             <p>The Kuxtal’s competitive advantage includes the offering of gene synthesis services within México, local production and commercialization, minimization of intermediaries and import regulatory bottlenecks, evasion of delays in delivery times and integral service (technical assistanece, quality product, efficient customer-supplier communication, customized attention).</p>
-
• Competitive prices.
+
-
• Local production and commercialization.
+
-
• Integral service (technical assistanece, quality product, efficient customer-supplier communication, customized attention).
+
-
• Different contact plattforms (web page, local phones, main offices) and payment options (credit cards, cash, discounts).</p>
+
                         </div>
                         </div>

Latest revision as of 00:24, 28 October 2012

Kuxtal

WHAT I CANNOT CREATE, I DO NOT UNDERSTAND RICHARD FEYNMAN’S
Anthony Quinn was the first Mexican actor to win an Academy Award.
He deserved it for his role in the 1952 movie Viva Zapata.

The company

Business concept.

Kuxtal Biotech is a mexican young company founded by 16 biotechnology engineers that will provide solutions and genomic services to it's target market: biotechnology laboratories, college laboratories, medical and private institutions, and research centers. It is focused on customized gene synthesis, validation and technical assistance.

Business philosophy.

Kuxtal Biotech's mission is to improve the quality of life of all human beings by enhancing the production and supply of effective medicines and treatments that will make use of synthetic biology/biotechnology knowledge.

As our vision, In 2020, Kuxtal Biotech will be a recognized company in gene synthesis production and synthetic biology area because of the excellence in quality as well as early delivery time in all the products and services provided.

The values that Kuxtal will manage are:
a) Innovation-By generating new ideas and making them come true. The company will be always looking for new biotechnological processes and services to offer.
b) Team work-By promoting share of ideas, efficient communication and coordinate activities to reach common objectives.
c) Ethics ans realiability- By behaving in a honest and responsable way, always trying to satisfy our customers with useful services and products.

Services provided.

Kuxtal Biotech provides oligonucleotide synthesis services, as well as assessment and consulting services.

The synthesis services will be performed with the highest quality standards with the services provided by Kuxtal biotech as the fastest in the market, and the consulting services provided in real time. The main focus of the synthesis will be primer synthesis for PCR techniques for the range between 20 and 30 bp, however other services will be available such as RNA and DNA synthesis for antisense and silencing techniques.

Kuxtal biotech will be ready to deliver gene synthesis of complex traits in the vector that the customer specifies. Synthesis products will be delivered lyophilized in 2 mL vials on a dry-ice container, along with a certificate of analysis that ensures quality. The products should be resuspended prior use, or stored at -20°C if they are to be used within a year from the synthesis date. Shipping costs will be charged to the customer.

As part of the quality promise, Kuxtal Biotech will evaluate all orders submitted and provide feedback to its costumers whenever possible to ensure every synthesis meets the needs and expectations of the clients.

Competitive advantage.

The Kuxtal’s competitive advantage includes the offering of gene synthesis services within México, local production and commercialization, minimization of intermediaries and import regulatory bottlenecks, evasion of delays in delivery times and integral service (technical assistanece, quality product, efficient customer-supplier communication, customized attention).